Differential gene and protein expression in abluminal sprouting and intraluminal splitting forms of angiogenesis

Clinical Science

Volumn 110, Issue 5, 2006, Pages 587-595

  Williams, James L ^a   Weichert, Alexander ^b   Zakrzewicz, Andreas ^b   Da Silva Azevedo, Luis ^b   Pries, Axel R ^b   Baum, Oliver ^c   Egginton, Stuart ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c UNIVERSITY OF BERN   (Switzerland)

Author keywords

Angiogenesis; Angiopoietin; Capillary splitting; Sprouting; Vascular endothelial growth factor (VEGF)

Indexed keywords

ANGIOPOIETIN 2; CD31 ANTIGEN; GELATINASE A; MATRIX METALLOPROTEINASE; MIDKINE; NEUROPILIN; OSTEONECTIN; RESTIN; THROMBOSPONDIN; TISSUE INHIBITOR OF METALLOPROTEINASE; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAPILLARY; CONTROLLED STUDY; ENDOTHELIUM CELL; EXTENSOR DIGITORUM LONGUS MUSCLE; EXTRACELLULAR MATRIX; GENE EXPRESSION; GENE TARGETING; IMMUNOBLOTTING; MALE; MOUSE; MUSCLE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; SPROUTING; UPREGULATION;

ANGIOGENIC PROTEINS; ANIMALS; CAPILLARIES; GENE EXPRESSION REGULATION; MALE; MICE; MICE, INBRED C57BL; MUSCLE PROTEINS; MUSCLE, SKELETAL; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC; PROTEIN ARRAY ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STRESS, MECHANICAL; VASODILATION;

EID: 33646712304     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20050185     Document Type: Article

References (47)

1. Carmeliet, P. (2003) Angiogenesis in health and disease. Nat. Med. 9, 653-660
2. Hudlicka, O. (1998) Is physiological angiogenesis in skeletal muscle regulated by changes in microcirculation? Microcirculation 5, 5-23
3. Zhou, A. L., Egginton, S., Brown, M. D. and Hudlicka, O. (1998) Capillary growth in overloaded, hypertrophic adult rat skeletal muscle: an ultrastructural study. Anat. Rec. 252, 49-63
4. 1-antagonist prazosin. Cell Tissue Res. 293, 293-303
5. Hansen-Smith, F. M., Hudlicka, O. and Egginton, S. (1996) In vivo angiogenesis in adult rat skeletal muscle: early changes in capillary network architecture and ultrastructure. Cell Tissue Res. 286, 123-136
6. Prior, B. M., Lloyd, P. G., Yang, H. T. and Terjung, R. L. (2003) Exercise-induced vascular remodeling. Exercise Sport Sci. Rev. 31, 26-33
7. Harry, L. E. and Paleolog, E. M. (2003) From the cradle to the clinic: VEGF in developmental, physiological, and pathological angiogenesis. Birth Detects Res. Part C Embryo Today 69, 363-374
8. Rivilis, I., Milkiewicz, M., Boyd, P. et al. (2002) Differential involvement of MMP-2 and VEGF during muscle stretch-versus shear stress-induced angiogenesis. Am. J. Physiol. Heart Circ. Physiol. 283, H1430-H1438
9. Milkiewicz, M., Pugh, C. W. and Egginton, S. (2004) Inhibition of endogenous HIF inactivation induces angiogenesis in ischaemic skeletal muscles of mice. J. Physiol. 560, 21-26
10. Marshall, E. (2004) Getting the noise out of gene arrays. Science 306, 630-631
11. Stetler-Stevenson, W. G. (1999) Matrix metalloproteinases in angiogenesis: a moving target for therapeutic intervention. J. Clin. Invest. 103, 1237-1241
12. Lee, S., Jilani, S. M., Nikolova, G. V., Carpizo, D. and Iruela-Arispe, M. L. (2005) Processing of VEGF-A by matrix metalloproteinases regulates bioavailability and vascular patterning in tumors. J. Cell Biol. 169, 681-691
13. Haas, T. L., Milkiewicz, M., Davis, S. J. et al. (2000) Matrix metalloproteinase activity is required for activity-induced angiogenesis in rat skeletal muscle. Am. J. Physiol. Heart Circ. Physiol. 279, H1540-H1547
14. Motamed, K., Blake, D. J., Angello, J. C. et al. (2003) Fibroblast growth factor receptor-1 mediates the inhibition of endothelial cell proliferation and the promotion of skeletal myoblast differentiation by SPARC: a role for protein kinase A. J. Cell. Biochem. 90, 408-423
15. Framson, P. E. and Sage, E. H. (2004) SPARC and tumor growth: where the seed meets the soil? J. Cell. Biochem. 92, 679-690
16. Sage, E. H., Reed, M., Funk, S. E. et al. (2003) Cleavage of the matricellular protein SPARC by matrix metalloproteinase 3 produces polypeptides that influence angiogenesis. J. Biol. Chem. 278, 37849-37857
17. Adams, J. C. (1997) Thrombospondin-1. Int. J. Biochem. Cell Biol. 29, 861-865
18. Pompe, T., Markowski, M. and Werner, C. (2004) Modulated fibronectin anchorage at polymer substrates controls angiogenesis. Tissue Eng. 10, 841-848
19. Mekhail, K., Gunaratnam, L., Bonicalzi, M. E. and Lee, S. (2004) HIF activation by pH-dependent nucleolar sequestration of VHL. Nat. Cell Biol. 6, 642-647
20. Semenza, G. L. (2001) HIF-1 and mechanisms of hypoxia sensing. Curr. Opin. Cell Biol. 13, 167-171
21. Vincent, K. A., Shyu, K. G., Luo, Y. et al. (2000) Angiogenesis is induced in a rabbit model of hindlimb ischemia by naked DNA encoding an HIF-2α/VP16 hybrid transcription factor. Circulation 102, 2255-2261
22. Kietzmann, T. and Gorlach, A. (2005) Reactive oxygen species in the control of hypoxia-inducible factor-mediated gene expression. Semin. Cell Dev. Biol. 16, 474-486
23. Wagner, P. D. (2001) Skeletal muscle angiogenesis. A possible role for hypoxia. Adv. Exp. Med. Biol. 502, 21-38
24. Kim, C. H., Cho, Y. S., Chun, Y. S., Park, J. W. and Kim, M. S. (2002) Early expression of myocardial HIF-1α in response to mechanical stresses: regulation by stretch-activated channels and the phosphatidylinositol 3-kinase signaling pathway. Circ. Res. 90, E25-E33
25. Milkiewicz, M., Hudlicka, O., Verhaeg, J., Egginton, S. and Brown, M. D. (2003) Differential expression of Flk-1 and Flt-1 in rat skeletal muscle in response to chronic ischaemia: favourable effect of muscle activity. Clin. Sci. 105, 473-482
26. 121. J. Biol. Chem. 276, 25520-25531
27. Murga, M., Fernandez-Capetillo, O. and Tosato, G. (2005) Neuropilin-1 regulates attachment in human endothelial cells independently of vascular endothelial growth factor receptor-2. Blood 105, 1992-1999
28. Pierre, P., Scheel, J., Rickard, J. E. and Kreis, T. E. (1992) CLIP-170 links endocytic vesicles to microtubules. Cell 70, 887-900
29. Fukata, M., Watanabe, T., Noritake, J. et al. (2002) Rac1 and Cdc42 capture microtubules through IQGAP1 and CLIP-170. Cell 109, 873-885
30. Choudhuri, R., Zhang, H. T., Donnini, S., Ziehe, M. and Bicknell, R. (1997) An angiogenic role for the neurokines midkine and pleiotrophin in tumorigenesis. Cancer Res. 57, 1814-1819
31. Harvey, B. K., Shen, H., Chen, G. J., Yoshida, Y. and Wang, Y. (2004) Midkine and retinoic acid reduce cerebral infarction induced by middle cerebral artery ligation in rats. Neurosci. Lett. 369, 138-141
32. Reynolds, P. R., Mucenski, M. L., Le Cras, T. D., Nichols, W. C. and Whitsett, J. A. (2004) Midkine is regulated by hypoxia and causes pulmonary vascular remodeling. J. Biol. Chem. 279, 37124-37132
33. 2+ signaling and nitric oxide production in endothelial cells. Biochem. Biophys. Res. Commun. 276, 830-836
34. Pipili-Synetos, E., Sakkoula, E. and Maragoudakis, M. E. (1993) Nitric oxide is involved in the regulation of angiogenesis. Br. J. Pharmacol. 108, 855-857
35. Parenti, A., Morbidelli, L., Cui, X. L. et al. (1998) Nitric-oxide is an upstream signal of vascular endothelial growth factor-induced extracellular signal-regulated kinase1/2 activation in postcapillary endothelium. J. Biol. Chem. 273, 4220-4226
36. Morbidelli, L., Chang, C. H., Douglas, J. G., Granger, H. J., Ledda, F. and Ziehe, M. (1996) Nitric oxide mediates mitogenic effect of VEGF on coronary venular endothelium. Am. J. Physiol. 270, H411-H415
37. Baum, O., Da Silva-Azevedo, L., Willerding, G. et al. (2004) Endothelial NOS is main mediator for shear stress-dependent angiogenesis in skeletal muscle after prazosin administration. Am. J. Physiol. Heart Circ. Physiol. 287, H2300-H2308
38. Zachary, I. (2003) VEGF signalling: integration and multi-tasking in endothelial cell biology. Biochem. Soc. Trans. 31, 1171-1177
39. Friedlander, M., Theesfeld, C. L., Sugita, M. et al. (1996) Involvement of integrins αvβ3 and αvβ5 in ocular neovascular diseases. Proc. Natl. Acad. Sci. U.S.A. 93, 9764-9769
40. Brown, M. D., Walter, H., Hansen-Smith, F. M., Hudlicka, O. and Egginton, S. (1998) Lack of involvement of basic fibroblast growth factor (FGF-2) in capillary growth in skeletal muscles exposed to long-term contractile activity. Angiogenesis 2, 81-91
41. Levy, A. P., Levy, N. S., Wegner, S. and Goldberg, M. A. (1995) Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia. J. Biol. Chem. 270, 13333-13340
42. DeLisser, H. M., Christofidou-Solomidou, M., Strieter, R. M. et al. (1997) Involvement of endothelial PECAM-1/CD31 in angiogenesis. Am. J. Pathol. 151, 671-677
43. Gale, N. W. and Yancopoulos, G. D. (1999) Growth factors acting via endothelial cell-specific receptor tyrosine kinases: VEGFs, angiopoietins, and ephrins in vascular development. Genes Dev. 13, 1055-1066
44. Asahara, T., Chen, D., Takahashi, T. et al. (1998) Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovascularization. Circ. Res. 83, 233-240
45. Chen, J. X., Chen, Y., DeBusk, L., Lin, W. and Lin, P. C. (2004) Dual functional roles of Tie-2/angiopoietin in TNF-α-mediated angiogenesis. Am. J. Physiol. Heart Circ. Physiol. 287, H187-H195
46. Tait, C. R. and Jones, P. F. (2004) Angiopoietins in tumours: the angiogenic switch. J. Pathol. 204, 1-10
47. Carmeliet, P. and Jain, R. K. (2000) Angiogenesis in cancer and other diseases. Nature (London) 407, 249-257